Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thyroid hormone excess and osteoporosis

G Leb1, H Warnkross, B Obermayer-Pietsch

  • 1Medical University Clinic, Karl Franzens University, Graz, Austria.

Acta Medica Austriaca
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Previous fracture and subsequent fracture risk: a meta-analysis to update FRAX.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2023
Same author

Update of the fracture risk prediction tool FRAX: a systematic review of potential cohorts and analysis plan.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2022
Same author

Clinical utility of bone markers in various diseases.

Bone·2018
Same author

Effect of vitamin D3 on bone turnover markers in critical illness: post hoc analysis from the VITdAL-ICU study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2017
Same author

International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2017
Same author

High salivary testosterone-to-androstenedione ratio and adverse metabolic phenotypes in women with polycystic ovary syndrome.

Clinical endocrinology·2017

Hyperthyroidism and thyroid hormone therapy can affect bone health, but evidence linking them to severe osteoporosis is inconsistent. Risk factors for bone loss include age, menopause, and thyroidectomy, not necessarily hormone therapy itself.

Area of Science:

  • Endocrinology
  • Bone Metabolism
  • Thyroid Disorders

Background:

  • Hyperthyroidism and thyroid hormone therapy are associated with bone metabolism.
  • Existing clinical data on their effects on bone are inconsistent.
  • Understanding these relationships is crucial for managing bone health in patients with thyroid conditions.

Purpose of the Study:

  • To review current understanding of hyperthyroidism and bone disease.
  • To analyze the impact of TSH-suppressive and non-suppressive thyroid hormone therapy on bone.
  • To identify risk factors for thyroid hormone-induced osteopenia.

Main Methods:

  • Literature review of current thinking and available clinical data.
  • Discussion of studies examining thyroid hormone therapy and bone effects.

Related Experiment Videos

  • Analysis of risk factors associated with thyroid hormone-induced osteopenia.

    • Main Results:

    • Data on hyperthyroidism and bone disease are inconsistent.
    • Risk factors for thyroid hormone-induced osteopenia include long-standing hyperthyroidism, old age, menopause, and total thyroidectomy.
    • Thyroid hormone therapy, regardless of TSH suppression, has not been definitively linked to manifest osteoporosis.

    Conclusions:

    • While hyperthyroidism and certain factors increase osteopenia risk, thyroid hormone therapy is not proven to cause overt osteoporosis.
    • Early diagnosis and treatment of hyperthyroidism are key.
    • Further research may clarify the nuanced relationship between thyroid status, therapy, and bone density.